Precision Medicine Advancements, Expanding Genomic Research, and Technological Innovation Drive Growth in the Global Biobanking Market

Biobanking market was valued at $8.3 billion in 2024 and is projected to reach $20.1 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025–2035). The global biobanking market is experiencing strong growth as precision medicine initiatives gain momentum across healthcare systems worldwide. Increasing reliance on well-characterized biological samples to support personalized therapies and disease-specific treatment strategies is driving demand for large-scale, high-quality biobanks. These repositories play a critical role in enabling translational research and clinical decision-making.

Browse the full report description of “Biobanking Market Size, Share & Trends Analysis Report by Product (Equipment, Consumables, Services, And Software & Informatics) By Sample Type (Blood & Blood Products, Human Tissues, Cell Lines / Primary Cells / Pbmcs / Stem Cells, Nucleic Acids, Biological Fluids, And Microbiome) and by Application (Research & Academic Studies, Drug Discovery & Development, Diagnostics & Biomarker Development, Regenerative Medicine, Precision/Personalized Medicine And Epidemiology, Forensics, And Others) Forecast Period (2025-2035)” of https://www.omrglobal.com/industry-reports/biobanking-market

Simultaneously, the rapid expansion of genomic research is accelerating biobank utilization across academia, pharmaceuticals, and biotechnology firms. Technological innovations such as automated sample handling, digital inventory management, and advanced cryopreservation are improving sample integrity, traceability, and scalability, further strengthening the role of biobanking in modern biomedical research.

Global Developments Highlight Accelerating Biobanking Adoption

• 2025: Major healthcare research networks expanded national biobanking programs to support population-scale genomic studies focused on cancer, rare diseases, and chronic conditions.
• 2024-2025: Biopharmaceutical companies increased collaborations with academic biobanks to secure high-quality biospecimens for drug discovery and biomarker validation programs.
• 2025: Adoption of automated storage, robotic sample retrieval, and cloud-based biobank management systems rose significantly, improving scalability and compliance with global data and biospecimen standards.

Strategic Investments and Digital Transformation Reshape Industry Landscape

Biobanking organizations and solution providers are investing in automation, AI-enabled data analytics, and integrated informatics platforms to enhance operational efficiency and sample usability. Partnerships between biobanks, research institutions, and biopharmaceutical companies are also increasing, supporting long-term sample access, data sharing, and commercialization of precision medicine discoveries.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• Product
• Sample Type
• Application

• Competitive Landscape – Avantor Inc., Hamilton Co., Merck KGaA, QIAGEN and Thermo Fisher Scientific Inc.

 Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

 Global Biobanking Market Report Segment

By Product

• Equipment
• Consumables
• Services
• Software & Informatics

By Sample Type

• Blood & Blood Products
• Human Tissues
• Cell lines / Primary Cells / PBMCs / Stem Cells
• Nucleic Acids
• Biological Fluids
• Microbiome

By Application

• Research & academic studies
• Drug discovery & development
• Diagnostics & biomarker development
• Regenerative medicine
• Precision/personalized medicine and epidemiology
• Forensics
• Others

Global Biobanking Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

 To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biobanking-market